Susan Gilmour

Dr. Gilmour is defining mechanisms by which tumor modifiers, such as polyamines and thrombin, support and accelerate the development of cancer to a malignant, metastatic state. She is also investigating how polyamines recruit mutant stem cell populations to promote the early development of tumors. She is translating these basic research findings into novel polyamine- and thrombin-targeted therapies that can contribute to increased survival in cancer patients.